Literature DB >> 24261394

Current update on medullary thyroid carcinoma.

Dhakshinamoorthy Ganeshan1, Erik Paulson, Cihan Duran, Maria E Cabanillas, Naifa L Busaidy, Chusilp Charnsangavej.   

Abstract

OBJECTIVE: This article will review the multimodality imaging spectrum of medullary thyroid carcinoma (MTC) with an emphasis on anatomic and functional imaging. Recent advances in the molecular cytogenetics of this tumor and the impact on diagnosis, prognosis, and development of novel targeted therapy will be discussed.
CONCLUSION: MTC is a neuroendocrine tumor with unique clinicopathologic and radiologic features compared with other thyroid malignancies. Imaging plays an important role in the optimal management of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261394     DOI: 10.2214/AJR.12.10370

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  [Imaging of medullary thyroid carcinoma].

Authors:  M Uhrig; S Delorme
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

2.  Hepatic Lesions in a Cirrhotic Liver: Primary or Metastases?

Authors:  Lorenzo Mannelli; Serena Monti; Verena Grieco; Manuela Matesan
Journal:  J Nucl Med Technol       Date:  2017-02-02

3.  68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging.

Authors:  Lilian Yuri Itaya Yamaga; Marcelo L Cunha; Guilherme C Campos Neto; Marcio R T Garcia; Ji H Yang; Cleber P Camacho; Jairo Wagner; Marcelo B G Funari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-20       Impact factor: 9.236

4.  Medullary thyroid carcinoma: Application of Thyroid Imaging Reporting and Data System (TI-RADS) Classification.

Authors:  Gabin Yun; Yeo Koon Kim; Sang Il Choi; Ji-Hoon Kim
Journal:  Endocrine       Date:  2018-04-21       Impact factor: 3.633

5.  CT and MR imaging of thyroid carcinoma showing thymus-like differentiation (CASTLE): a report of ten cases.

Authors:  Bin Wu; Tuanqi Sun; Yajia Gu; Weijun Peng; Zhuoying Wang; Rui Bi; Qinghai Ji
Journal:  Br J Radiol       Date:  2016       Impact factor: 3.039

6.  Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.

Authors:  O Hamdy; S Awny; I H Metwally
Journal:  Ann R Coll Surg Engl       Date:  2020-04-01       Impact factor: 1.891

Review 7.  Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.

Authors:  Maximilian Klingler; Anton Amadeus Hörmann; Elisabeth Von Guggenberg
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

8.  High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.

Authors:  Shih-Wei Chen; Yen-Kung Chen
Journal:  World J Surg Oncol       Date:  2017-12-29       Impact factor: 2.754

9.  Clinical value of color Doppler ultrasound combined with serum tumor markers for the diagnosis of medullary thyroid carcinoma.

Authors:  Xue Yang; Jinjuan Xu; Jilan Sun; Lizhi Yin; Rui Guo; Zhimei Yan
Journal:  Oncol Lett       Date:  2021-05-27       Impact factor: 2.967

10.  Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors.

Authors:  Masayuki Hijioka; Tetsuhide Ito; Hisato Igarashi; Nao Fujimori; Lingaku Lee; Taichi Nakamura; Robert T Jensen; Ryoichi Takayanagi
Journal:  Cancer Sci       Date:  2014-10-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.